<DOC>
	<DOCNO>NCT01162200</DOCNO>
	<brief_summary>By use stereotactic body radiation therapy ( SBRT ) deliver Cyberknife system® , current protocol attempt mimic improve excellent local control rate see treatment early stage breast cancer attempt increase convenience , limit invasiveness , decrease toxicity , improve cosmesis compare method radiation treatment .</brief_summary>
	<brief_title>Cyberknife® Partial Breast Irradiation ( PBI ) Early Stage Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DCIS invasive ductal , medullary , papillary , mucinous ( colloid ) , tubular histology . Eligible patient must appropriate stag study identify AJCC stage T1 T2 ( ≤3 cm ) treat lumpectomy axillary node dissection least 6 node sample sentinel node biopsy . Patients 3 positive node without microscopic macroscopic evidence extracapsular extension eligible . The patient 's Zubrod performance status must 02 . Patients must ≥ 18 year age . If chemotherapy plan , must begin earlier two week follow completion radiation therapy . Unifocal breast cancer ( evidence gross multifocal disease , multicentric , bilateral disease . Negative margin lumpectomy ( reexcision initial positive margin allowednegative margin define &gt; 2 mm clear tumor direction ) . Negative post lumpectomy mammography malignancyassociated microcalcifications initially present . The target lumpectomy cavity must clearly delineate . Patients must complete appropriate pretreatment evaluation , include postlumpectomy mammogram microcalcifications initially present confirm complete removal . Evidence suspicious microcalcifications breast prior start radiation . Patients history collagen vascular disease , specifically dermatomyositis CPK level normal active skin rash , systemic lupus erythematosis , scleroderma . Patients 4 histologically positive axillary node axillary dissection perform . Patients distant metastasis . Patients invasive extensive insitu lobular carcinoma nonepithelial breast malignancy sarcoma lymphoma . Patients multicentric gross disease define tumor different quadrant breast tumor separate least 4 cm clinically radiographically suspicious area ipsilateral breast unless confirm negative malignancy biopsy . Patients must palpable radiographically suspicious ipsilateral contralateral axillary , supraclavicular , infraclavicular , internal mammary node unless histologic confirmation node negative tumor . Any previously treat contralateral invasive breast carcinoma synchronous contralateral breast carcinoma . Prior nonhormonal therapy radiation therapy current breast cancer hormonal therapy &gt; 28 day diagnosis refusal discontinue hormonal therapy . Patients Paget 's disease nipple Patients prior invasive malignancy ( except nonmelanomatous skin cancer ) unless disease free minimum 3 year ( e.g. , carcinoma situ breast , oral cavity , cervix permissible ) . Patients severe , active comorbidity . Patients psychiatric addictive disorder , opinion investigator , would preclude obtain informed consent . Patients pregnant lactate . Previous breast radiation either side thoracic radiation ipsilateral side..</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>